Recce Pharmaceuticals Ltd
ASX:RCE.AX
0.515 (AUD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -17.662 | -13.077 | -10.986 | -13.513 | -4.317 | -2.789 | -1.674 | -3.026 | -4.84 | -0.45 | -0.272 | -0.292 |
| Depreciation & Amortization
| 0.367 | 0.217 | 0.188 | 0.296 | 0.201 | 0.056 | 0.053 | 0.026 | 0.016 | 0.01 | 0 | 0 |
| Deferred Income Tax
| 0 | 0.098 | -0.456 | -5.729 | -0.284 | 0 | -0.11 | 0.008 | -3.298 | -0.076 | 0 | 0 |
| Stock Based Compensation
| 0 | 0.325 | 0.256 | 5.218 | 0.055 | 0 | 0.071 | 0.013 | 3.322 | 0.091 | 0.011 | 0 |
| Change In Working Capital
| 4.266 | -0.152 | 1.532 | 0.144 | 0.253 | -0.016 | 0.039 | -0.021 | -0.024 | -0.016 | 0 | 0 |
| Accounts Receivables
| 0.061 | 0.092 | 0.063 | -0.204 | -0.005 | -0.016 | 0.039 | -0.021 | -0.024 | -0.016 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | -0.137 | 0.272 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 3.815 | 0.766 | 0.113 | 0.284 | 0.178 | 0.089 | -0.301 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| 0.391 | -1.01 | 1.356 | 0.064 | 0.08 | 0.048 | 0.029 | 0.51 | -0.079 | 0.026 | 0 | 0 |
| Other Non Cash Items
| -3.122 | -0.098 | 0.456 | 5.729 | 0.284 | 0.137 | -0.111 | 0.51 | -0.081 | 0.069 | 0.261 | 0.292 |
| Operating Cash Flow
| -13.009 | -12.687 | -9.01 | -7.856 | -3.807 | -2.612 | -1.732 | -2.498 | -1.608 | -0.296 | 0.011 | 0 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -0.142 | -0.039 | -0.04 | -0.076 | -0.006 | -0.09 | -0.178 | -0.246 | -0.078 | -0.035 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.06 | 0 | 0 | 0 |
| Investing Cash Flow
| -0.142 | -0.039 | -0.04 | -0.076 | -0.006 | -0.09 | -0.178 | -0.246 | -0.018 | -0.035 | 0 | 0 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -5.886 | -2.878 | -0.139 | -0.175 | -0.737 | -0.735 | -0.003 | -0.007 | -0.119 | 0 | 0 | 0 |
| Common Stock Issued
| 10.583 | 0.102 | 0.287 | 26.338 | 6.98 | 1.691 | 1.497 | 0 | 4.759 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | -1.719 | -1.719 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -0.163 | 5.482 | 3.049 | 3.397 | -0.15 | 1.469 | 0.006 | 0.25 | 0.126 | 0.689 | 0 | 0 |
| Financing Cash Flow
| 16.004 | 2.706 | -0.24 | 26.123 | 6.092 | 2.426 | 1.499 | 0.243 | 4.766 | 0.689 | 0 | 0 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.094 | 0 | 0 |
| Net Change In Cash
| 2.646 | -10.02 | -9.291 | 18.191 | 2.279 | -0.276 | -0.411 | -2.501 | 3.14 | 0.452 | 0.011 | 0 |
| Cash At End Of Period
| 4.207 | 1.562 | 11.582 | 20.873 | 2.682 | 0.403 | 0.68 | 1.09 | 3.591 | 0.452 | 0.011 | 0 |